Back to search

Realisation B 2024 Ltd

12168524

in administration/administrative receiver
Private Limited Company
Companies House
Health Score
N/A

Details

7TH FLOOR, LONDON, EC3V 9AH
Incorporated 21/08/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

21100
Manufacture of basic pharmaceutical products
21200
Manufacture of pharmaceutical preparations
46460
Wholesale of pharmaceutical goods
86220
Specialist medical practice activities

Officers

Mr Eric Gustaf Bystrom

director · Since 21/08/2019

COMPANY DIRECTOR

SWEDISH · UNITED KINGDOM · Age 43

Also on 2 other boards

Persons with Significant Control

Cellen Life Sciences Limited

75–100% shares
75–100% votes
Appoint directors

Cms Cameron Mckenna Nabarro Olswang Llp, Cannon Place, London, EC4N 6AF

Reg: 12164338 · Companies House · Limited By Shares

Notified 21/08/2019

CompanyRankvs 15+ SIC 21100 peers
24

Financial strengthNo net worth data · 0/25
EmployeesNo employee data · 0/15
LiquidityCurrent ratio 0.08× · 2/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2023

Net Worth

-£959k

Balance sheet strength

Cash

£36k

Cash in the bank

Net Current Assets

-£754k

Working capital

Current Assets

£63k

Current Liabilities

£817k

Fixed Assets

£1k

Debtors

£27k

1avg. employees-1

Tax at Year End

VAT£3k

Balance Sheet

Assets less current liabilities-£753k
Signed by Mr Eric Bystrom 29/02/2024Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied ProfitEst. Revenue
20230.08-£749k£68k
20220.55-£53k
202130.85-£81k
202011.73

Derived from filed accounts. Not audited figures.